Model
Edge
Revance Therapeutics Inc.
0001635046
Filing Type
4/A
Filing Date
5/12/2022
Updated
5/13/22, 12:13 PM
Filing
4/A
Earnings Release
Exhibits
4/A
Amended Statement of Changes in Beneficial Ownership